CME/CE
CME/CE CoursesYour search for high-quality, complimentary CME/CE stops right here. The courses below are presented by myCME, the continuing education engine in Haymarket Medical Network’s (HMN) expanding portfolio of clinical websites. Below you’ll find practice-relevant courses that carry valuable CME/CE credit. Simply click any link to get started earning credit on myCME. |
Featured Courses
Virtual Patient: Comorbid Obesity in T2DM | myCME
1.00 CME CNE: To enhance your ability to treat patients with these 2 highly prevalent conditions, we invite you to participate in this interactive CME series via 3 interactive patient simulations. Exp 12/9/23
Practical Strategies for Probiotics in Neonatal Healthcare | myCME
0.75 CME: Experts provide an in-depth review of the most-recent evidence of the effectiveness, safety, and quality of probiotics in at-risk neonates. Exp 5/12/23
Understanding Lysosomal Storage Disorders | myCME
1.00 CME CE: General characteristics and clinical markers to aid recognition of Lysosomal Storage Disorders and key studies regarding therapy. Exp 12/6/23
Optimizing Treatment in Patients With HIV | myCME
0.75 CME: Covers evidence/guidelines for ART optimization in treatment-experienced patients with HIV and overview of emerging antiretrovirals. Exp 6/21/23
Maternal Alloimmunization and Hemolytic Disease of the Fetus and Newborn | myCME
1.50 CME CE: Interactive course discusses the pathogeneses of MA and HDFN, traditional management, and potential to integrate FcRn inhibitors. Exp 7/27/23
Advancing Therapy in Moderate-to-Severe Atopic Dermatitis | myCME
1.25 CME CE: This activity focuses on incorporating new therapies for the management of moderate-to-severe Atopic Dermatitis. Exp 6/30/23
The Impact of OSA-Related EDS on HRQoL | myCME
0.50 CME CE: Case 1 of 3-part series provides insight into the extensive impact of OSA-related EDS on psychosocial functioning and HRQoL. Exp. 5/11/23
Treatment Decisions for Patients with HCV and CKD | myCME
0.50 CME CE: This CMEO BriefCase will introduce a complex HCV case involving a patient with HCV and chronic kidney disease. Exp 5/17/23
Treatment Selection in a Patient with Decompensated Cirrhosis | myCME
0.50 CME CE: This CMEO BriefCase will introduce a case involving the incorporation of routine surveillance for HCC in a patient with HCV. Exp 5/17/23
Game-changers in Atopic Dermatitis and Alopecia Areata | myCME
2.00 CME CE: Provides education for advanced practice providers on the current and emerging therapies in atopic dermatitis and alopecia areata. Exp 6/1/23
Upstream Mediators With Next-Generation Biologics | myCME
0.75 CME: Provides clinicians with an understanding of the unmet needs in severe asthma, the alarmin pathway, and novel biologic therapies. Exp 7/29/23
Minimally Invasive Outpatient Procedures for BPH | myCME
1.25 CME CE: Three experts review strategies for identifying patients with BPH and clinical data on minimally invasive procedures. Exp 4/15/2023
More
A Deep Dive on Novel and Emerging Evidence in the Treatment of HR+/HER2- Breast Cancer
A Deep Dive on Novel and Emerging Evidence in the Treatment of HR+/HER2- Breast Cancer
Leveraging Expert-Informed Adverse Event Management and Supportive Care Strategies to Improve Patient Outcomes in Bladder Cancer
Leveraging Expert-Informed Adverse Event Management and Supportive Care Strategies to Improve Patient Outcomes in Bladder Cancer
Recurrent C. difficile and Microbiota-Based Biotherapies | myCME
1.25 CME: Clinicians will learn about the risk factors for C. diff recurrence, current guidelines, and treatment. Microbiota restoration therapies are discussed. Exp 9/7/23
Detection and Appropriate Treatment of Ocular Diseases | myCME
1.50 CME CE: The importance of early detection and appropriate treatment of ocular diseases for maintaining optimal vision and preventing adverse outcomes. Exp 1/31/24
SLIT Tablets for Allergic Rhinitis and Rhinoconjunctivitis | myCME
1.00 CME: Patient selection criteria, access to specialty treatment, and other barriers have complicated the use of allergen immunotherapy for AR and ARC. Exp 3/17/24
Improving Your OAB Care: A Focus on the Elderly and Male Patients | myCME
Identify LUTS in male patients that may represent BPH, OAB, or a combination of both. Discuss recent data on therapeutic options to manage OAB-wet and OAB-dry patients. Individualize the management of elderly patients with OAB, considering medication burden, comorbidities, and cognitive status.
Lipid Management That Reduces Major CV Risks | myCME
0.50 CME CE: Integrate current and emerging data into the management of patients with chronic HFpEF. Exp 4/16/23
Atopic Dermatitis: Pediatric Personalized Management Plans | myCME
0.25 CME CNE: Recognizing the signs and symptoms of pediatric AD and choosing the most appropriate therapy based on an interactive clinical scenario. Exp 1/31/24
NAFLD and NASH: Applying the AACE Guideline | myCME
CME CE 3.00: Identify and care for patients at risk of developing nonalcoholic fatty liver disease and nonalcoholic steatohepatitis to prevent disease progression. Exp 2/28/24
12-Lead ECG Course (30 hrs Cat I CME/CE) | myCME
Learn to analyze, not memorize, with The 12-Lead ECG Course. A hybrid of online material and written material, this course is made for flexible home/self-study. Review the normal pattern, STEMI, nonSTEMI, Bundle Branch Blocks, LAFB, LVH, and WPW and ultimately learn how to analyze changes associated with acute MI/ischemia. Learn more and view a course outline.
